title: Lowering the criterion for impaired fasting glucose will not provide clinical benefit.
authors.affiliation: Clinical Trials Unit, Charles R. Drew University, Los Angeles, California 90059, USA.
authors.forename: Mayer B
authors.initials: MB
authors.lastname: Davidson
authors.forename: Pamela B
authors.initials: PB
authors.lastname: Landsman
authors.forename: Charles M
authors.initials: CM
authors.lastname: Alexander
mesh_terms: D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000378:metabolism*; D005006:Ethnicity; D005215:Fasting; D005260:Female; D018149:Glucose Intolerance / Q000145:classification*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D012016:Reference Values; D015203:Reproducibility of Results
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin